English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 60 | Tables: 64 | Medical Care
The global market for Oncolytic Bacterial Drugs was valued at US$ 147 million in the year 2024 and is projected to reach a revised size of US$ 212 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Oncolytic Bacterial Drugs are a class of drugs that utilize specific bacteria with selective killing effects on tumor cells. These bacteria can recognize and infect tumor cells, releasing tumor-associated antigens through replication and lysis of tumor cells, thereby stimulating the body's antitumor immune response. Oncolytic Bacterial Drugs offer unique tumor targeting and immune-activating properties, providing new strategies for cancer treatment. Compared with traditional chemotherapy and radiotherapy, oncolytic bacterial drugs have lower toxicity and better tolerability, while stimulating the body's own immune system to combat tumors. In addition, oncolytic bacterial drugs can be used in combination with other treatment methods to enhance therapeutic effects and reduce side effects. Currently, several oncolytic bacterial drugs have entered clinical trial phases, demonstrating promising therapeutic prospects.
North American market for Oncolytic Bacterial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncolytic Bacterial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oncolytic Bacterial Drugs in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oncolytic Bacterial Drugs include Salvector, Guangzhou Sinogen Pharmaceutical, HKND YB1 PHARMACEUTUCAL, Shandong Xinchuang Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Bacterial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Bacterial Drugs.
The Oncolytic Bacterial Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Bacterial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Bacterial Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salvector
Guangzhou Sinogen Pharmaceutical
HKND YB1 PHARMACEUTUCAL
Shandong Xinchuang Biotechnology
Segment by Type
Intratumoral Injection
Intravenous Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Bacterial Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Bacterial Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intratumoral Injection
1.2.3 Intravenous Injection
1.3 Market by Application
1.3.1 Global Oncolytic Bacterial Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Bacterial Drugs Market Perspective (2020-2031)
2.2 Global Oncolytic Bacterial Drugs Growth Trends by Region
2.2.1 Global Oncolytic Bacterial Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncolytic Bacterial Drugs Historic Market Size by Region (2020-2025)
2.2.3 Oncolytic Bacterial Drugs Forecasted Market Size by Region (2026-2031)
2.3 Oncolytic Bacterial Drugs Market Dynamics
2.3.1 Oncolytic Bacterial Drugs Industry Trends
2.3.2 Oncolytic Bacterial Drugs Market Drivers
2.3.3 Oncolytic Bacterial Drugs Market Challenges
2.3.4 Oncolytic Bacterial Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Bacterial Drugs Players by Revenue
3.1.1 Global Top Oncolytic Bacterial Drugs Players by Revenue (2020-2025)
3.1.2 Global Oncolytic Bacterial Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Oncolytic Bacterial Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncolytic Bacterial Drugs Revenue
3.4 Global Oncolytic Bacterial Drugs Market Concentration Ratio
3.4.1 Global Oncolytic Bacterial Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Bacterial Drugs Revenue in 2024
3.5 Global Key Players of Oncolytic Bacterial Drugs Head office and Area Served
3.6 Global Key Players of Oncolytic Bacterial Drugs, Product and Application
3.7 Global Key Players of Oncolytic Bacterial Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Bacterial Drugs Breakdown Data by Type
4.1 Global Oncolytic Bacterial Drugs Historic Market Size by Type (2020-2025)
4.2 Global Oncolytic Bacterial Drugs Forecasted Market Size by Type (2026-2031)
5 Oncolytic Bacterial Drugs Breakdown Data by Application
5.1 Global Oncolytic Bacterial Drugs Historic Market Size by Application (2020-2025)
5.2 Global Oncolytic Bacterial Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncolytic Bacterial Drugs Market Size (2020-2031)
6.2 North America Oncolytic Bacterial Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncolytic Bacterial Drugs Market Size by Country (2020-2025)
6.4 North America Oncolytic Bacterial Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Bacterial Drugs Market Size (2020-2031)
7.2 Europe Oncolytic Bacterial Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncolytic Bacterial Drugs Market Size by Country (2020-2025)
7.4 Europe Oncolytic Bacterial Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Bacterial Drugs Market Size (2020-2031)
8.2 Asia-Pacific Oncolytic Bacterial Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Bacterial Drugs Market Size (2020-2031)
9.2 Latin America Oncolytic Bacterial Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncolytic Bacterial Drugs Market Size by Country (2020-2025)
9.4 Latin America Oncolytic Bacterial Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Bacterial Drugs Market Size (2020-2031)
10.2 Middle East & Africa Oncolytic Bacterial Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Salvector
11.1.1 Salvector Company Details
11.1.2 Salvector Business Overview
11.1.3 Salvector Oncolytic Bacterial Drugs Introduction
11.1.4 Salvector Revenue in Oncolytic Bacterial Drugs Business (2020-2025)
11.1.5 Salvector Recent Development
11.2 Guangzhou Sinogen Pharmaceutical
11.2.1 Guangzhou Sinogen Pharmaceutical Company Details
11.2.2 Guangzhou Sinogen Pharmaceutical Business Overview
11.2.3 Guangzhou Sinogen Pharmaceutical Oncolytic Bacterial Drugs Introduction
11.2.4 Guangzhou Sinogen Pharmaceutical Revenue in Oncolytic Bacterial Drugs Business (2020-2025)
11.2.5 Guangzhou Sinogen Pharmaceutical Recent Development
11.3 HKND YB1 PHARMACEUTUCAL
11.3.1 HKND YB1 PHARMACEUTUCAL Company Details
11.3.2 HKND YB1 PHARMACEUTUCAL Business Overview
11.3.3 HKND YB1 PHARMACEUTUCAL Oncolytic Bacterial Drugs Introduction
11.3.4 HKND YB1 PHARMACEUTUCAL Revenue in Oncolytic Bacterial Drugs Business (2020-2025)
11.3.5 HKND YB1 PHARMACEUTUCAL Recent Development
11.4 Shandong Xinchuang Biotechnology
11.4.1 Shandong Xinchuang Biotechnology Company Details
11.4.2 Shandong Xinchuang Biotechnology Business Overview
11.4.3 Shandong Xinchuang Biotechnology Oncolytic Bacterial Drugs Introduction
11.4.4 Shandong Xinchuang Biotechnology Revenue in Oncolytic Bacterial Drugs Business (2020-2025)
11.4.5 Shandong Xinchuang Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Bacterial Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intratumoral Injection
Table 3. Key Players of Intravenous Injection
Table 4. Global Oncolytic Bacterial Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oncolytic Bacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncolytic Bacterial Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oncolytic Bacterial Drugs Market Share by Region (2020-2025)
Table 8. Global Oncolytic Bacterial Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oncolytic Bacterial Drugs Market Share by Region (2026-2031)
Table 10. Oncolytic Bacterial Drugs Market Trends
Table 11. Oncolytic Bacterial Drugs Market Drivers
Table 12. Oncolytic Bacterial Drugs Market Challenges
Table 13. Oncolytic Bacterial Drugs Market Restraints
Table 14. Global Oncolytic Bacterial Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oncolytic Bacterial Drugs Market Share by Players (2020-2025)
Table 16. Global Top Oncolytic Bacterial Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Bacterial Drugs as of 2024)
Table 17. Ranking of Global Top Oncolytic Bacterial Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oncolytic Bacterial Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oncolytic Bacterial Drugs, Headquarters and Area Served
Table 20. Global Key Players of Oncolytic Bacterial Drugs, Product and Application
Table 21. Global Key Players of Oncolytic Bacterial Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Bacterial Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oncolytic Bacterial Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Oncolytic Bacterial Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oncolytic Bacterial Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Oncolytic Bacterial Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oncolytic Bacterial Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Oncolytic Bacterial Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oncolytic Bacterial Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oncolytic Bacterial Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Salvector Company Details
Table 47. Salvector Business Overview
Table 48. Salvector Oncolytic Bacterial Drugs Product
Table 49. Salvector Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 50. Salvector Recent Development
Table 51. Guangzhou Sinogen Pharmaceutical Company Details
Table 52. Guangzhou Sinogen Pharmaceutical Business Overview
Table 53. Guangzhou Sinogen Pharmaceutical Oncolytic Bacterial Drugs Product
Table 54. Guangzhou Sinogen Pharmaceutical Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 55. Guangzhou Sinogen Pharmaceutical Recent Development
Table 56. HKND YB1 PHARMACEUTUCAL Company Details
Table 57. HKND YB1 PHARMACEUTUCAL Business Overview
Table 58. HKND YB1 PHARMACEUTUCAL Oncolytic Bacterial Drugs Product
Table 59. HKND YB1 PHARMACEUTUCAL Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 60. HKND YB1 PHARMACEUTUCAL Recent Development
Table 61. Shandong Xinchuang Biotechnology Company Details
Table 62. Shandong Xinchuang Biotechnology Business Overview
Table 63. Shandong Xinchuang Biotechnology Oncolytic Bacterial Drugs Product
Table 64. Shandong Xinchuang Biotechnology Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 65. Shandong Xinchuang Biotechnology Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Oncolytic Bacterial Drugs Picture
Figure 2. Global Oncolytic Bacterial Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncolytic Bacterial Drugs Market Share by Type: 2024 VS 2031
Figure 4. Intratumoral Injection Features
Figure 5. Intravenous Injection Features
Figure 6. Global Oncolytic Bacterial Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oncolytic Bacterial Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Oncolytic Bacterial Drugs Report Years Considered
Figure 12. Global Oncolytic Bacterial Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oncolytic Bacterial Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oncolytic Bacterial Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Oncolytic Bacterial Drugs Market Share by Players in 2024
Figure 16. Global Oncolytic Bacterial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oncolytic Bacterial Drugs Revenue in 2024
Figure 18. North America Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 20. United States Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 24. Germany Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncolytic Bacterial Drugs Market Share by Region (2020-2031)
Figure 32. China Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Salvector Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 48. Guangzhou Sinogen Pharmaceutical Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 49. HKND YB1 PHARMACEUTUCAL Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 50. Shandong Xinchuang Biotechnology Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
